Can we help?

call us on +44 (0)131 4456077
or email

Investor relations

Bespoke solutions from clinical trial to launch

Investor relations

Register for email alerts

Please use the form below to subscribe to email alerts.

Email address:
First name:
Surname:
Type of news
Press Regulatory Both
 

Contact us

for investor relations queries:
Lorna Peers
Finance Director and Company Secretary
Tel:+44 (0)131 4456077
enquiries@angelbio.com

Our services

Along with the successful production of recombinants, Angel provides development and process scale-up strategies

Our services